The MIF inhibitor ISO-1 attenuates HIF-1α- and cAMP-dependent cyst enlargement and can also be used as a therapeutic target to delay cyst growth in ADPKD [27] (Table 2). Here, HIF1A is linked to autosomal dominant polycystic kidney disease.